Home >> Product >> Egg Yolk Lecithin for Injection>> Egg Yolk Lecithin for Injection

Egg Yolk Lecithin for Injection

Egg Yolk Lecithin Egg Yolk Lecithin for Injection

Egg yolk lecithin is a natural phospholipid mixture extracted and refined from egg yolk, with phosphatidylcholine (PC) and phosphatidylethanolamine (PE) as the main components. It appears as an off-white or pale-yellow powder or block-like solid and feels slightly slippery to the touch.

product_details

  • Product Applications: Primarily used as an emulsifier in fat emulsions; it can also be used as a structural lipid in liposome formulations.
    • Fat Emulsions: Long-chain fat emulsion injection, medium/long-chain fat emulsion injection, multi-oil fat emulsion injection, fat emulsion amino acid glucose injection, medium-long-chain fat emulsion/amino acid/glucose injection; ω-3 fish oil medium-long-chain fat emulsion/amino acid/glucose injection; propofol emulsion injection, remimazolam injection, aprepitant injection, etomidate medium/long-chain fat emulsion injection, flurbiprofen axetil injection, etc.
    • Liposome Formulations: In water, they can self-assemble into vesicle structures with phospholipid bilayers, often used together with cholesterol in liposome formulations, serving as a key membrane material for liposomes.
  • Baiyunshan Hanfang Product CDE Filing Registration Numbers:
    • F20200000313  Status A
    • F20190001049  Status A
  • Baiyunshan Hanfang Product Quality Standards: Chinese Pharmacopoeia CP, United States Pharmacopeia USP, European Pharmacopoeia EP
  • Baiyunshan Hanfang Product Advantages:
    • Global Compliance and Adaptability: Complies with multiple pharmacopoeial standards such as ChP/USP/EP, enabling access to compliant markets in many countries. It is the first egg yolk lecithin product in China to obtain registration approval from the National Medical Products Administration, with approval number: National Drug Approval No. F20080006; it is also the first egg yolk lecithin product in China to file DMF registration for pharmaceutical excipients in the United States, with filing number: DMF 35483.
    • In-house R&D of Core Processes: Possesses the “National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation” accredited by the National Development and Reform Commission, leveraging the core technologies of the National Engineering Research Center to independently develop the core preparation process for egg yolk lecithin and pioneering domestic industrial-scale supply.
    • Flexible Customization: Excellent emulsifying performance and good solubility. Can provide higher-standard specifications according to customer needs, suitable for various formulation application scenarios.